Cited by 160Psychedelics and Drug StudiesPosttraumatic Stress Disorder ResearchPsychotherapy Techniques and Applications

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy

Open access
Wagner, Mark T, Mithoefer, Michael C, Mithoefer, Ann T, MacAulay, Rebecca K, Jerome, Lisa, Yazar-Klosinski, Berra, Doblin, Rick·2017·Journal of Psychopharmacology

Abstract

A growing body of research suggests that traumatic events lead to persisting personality change characterized by increased neuroticism. Relevantly, enduring improvements in Post-Traumatic Stress Disorder (PTSD) symptoms have been found in response to 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy. There is evidence that lasting changes in the personality feature of "openness" occur in response to hallucinogens, and that this may potentially act as a therapeutic mechanism of change. The present study investigated whether heightened Openness and decreased Neuroticism served as a mechanism of change within a randomized trial of MDMA-assisted psychotherapy for chronic, treatment-resistant PTSD. The Clinician-Administered PTSD Scale (CAPS) Global Scores and NEO PI-R Personality Inventory (NEO) Openness and Neuroticism Scales served as outcome measures. Results indicated that changes in Openness but not Neuroticism played a moderating role in the relationship between reduced PTSD symptoms and MDMA treatment. Following MDMA-assisted psychotherapy, increased Openness and decreased Neuroticism when comparing baseline personality traits with long-term follow-up traits also were found. These preliminary findings suggest that the effect of MDMA-assisted psychotherapy extends beyond specific PTSD symptomatology and fundamentally alters personality structure, resulting in long-term persisting personality change. Results are discussed in terms of possible mechanisms of psychotherapeutic change.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881117711712

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Placebo vs. MDMA-treatment group means and standard errors for Clinician-Administered PTSD Scale (CAPS) Global Scores at baseline and 2 months. Change in Openness served as a covariate. Results represent the main effect of PTSD symptom reduction and the moderating effect of increased openness on therapy outcomes; all p values < .05.
Figure 1. Placebo vs. MDMA-treatment group means and standard errors for Clinician-Administered PTSD Scale (CAPS) Global Scores at baseline and 2 months. Change in Openness served as a covariate. Results represent the main effect of PTSD symptom reduction and the moderating effect of increased openness on therapy outcomes; all p values < .05.CC BY-NC · PubMed Central
Figure 2. Placebo vs. MDMA-treatment group means and standard errors for Clinician-Administered PTSD Scale (CAPS) Global Scores at baseline and 2 months. Change in Neuroticism served as a covariate. Results represent the main effect of group and the effect of decreased Neuroticism on therapy outcomes; all p values < .05.
Figure 2. Placebo vs. MDMA-treatment group means and standard errors for Clinician-Administered PTSD Scale (CAPS) Global Scores at baseline and 2 months. Change in Neuroticism served as a covariate. Results represent the main effect of group and the effect of decreased Neuroticism on therapy outcomes; all p values < .05.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 6

  1. Blake DD, 1990, Behavior Therapy, 13, 187
  2. Costa PT, 1992, NEO PI-R Professional Manual
  3. First M, 1997, Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II): Interview and Questionnaire
  4. First MB, 1997, Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0, 4/97 Revision)
  5. 10.1038/sj.npp.1395197 · DOI · Paper page
  6. World Health Organization, 1992, The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines

Cited by

Sorted by citations

See all 160

Metadata

Authors
Wagner, M. T., Mithoefer, M. C., Mithoefer, A. T., MacAulay, R. K., Jerome, L., Yazar-Klosinski, B., & Doblin, R.
Affiliations
  • Medical University of South Carolina (US)
  • Private Practice, Mount Pleasant, USA
  • University of Maine (US)
  • MAPS Public Benefit Corp (MPBC), Santa Cruz, USA
  • Multidisciplinary Association for Psychedelic Studies, Santa Cruz, USA
  • Multidisciplinary Association for Psychedelic Studies (US)
Corresponding author
Wagner, Mark T
Venue
Journal of Psychopharmacology
Published
2017-06-21
Volume
31
Issue
8
Pages
967-974
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2716623847
Cited by
160
References
51
Citations by year
2026: 9 · 2025: 14 · 2024: 21 · 2023: 14 · 2022: 18 · 2021: 11 · 2020: 49 · 2019: 10 · 2018: 10 · 2017: 4
FWCI
24.76
Type
journal article
Language
en
Open access
Locations
  • Journal of Psychopharmacology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
MDMA-assisted psychotherapy, MDMA, post-traumatic stress disorder, treatment-resistant PTSD, personality change, openness to experience, neuroticism, mechanisms of change, hallucinogens, personality traits
MeSH terms
Neuroticism, Adult, Combined Modality Therapy, Female, Hallucinogens, Humans, Male, Personality Inventory, Psychotherapy, Stress Disorders, Post-Traumatic, Treatment Outcome, N-Methyl-3,4-methylenedioxyamphetamine, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review